BRIDION

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug BRIDION contains one active pharmaceutical ingredient (API):

1 Sugammadex UNII ERJ6X2MXV7 - SUGAMMADEX SODIUM

Sugammadex is a modified gamma cyclodextrin which is a Selective Relaxant Binding Agent. It forms a complex with the neuromuscular blocking agents rocuronium or vecuronium in plasma and thereby reduces the amount of neuromuscular blocking agent available to bind to nicotinic receptors in the neuromuscular junction. Read about Sugammadex

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BRIDION Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AB35	Sugammadex	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB35

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 537701002159212
Country: CA	Health Products and Food Branch	Identifier(s): 02451816
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4340-MEE-0818
Country: EE	Ravimiamet	Identifier(s): 1364701, 1364712
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08466001, 08466002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 140130, 140141
Country: FR	Base de données publique des médicaments	Identifier(s): 64333487
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147463, 147466
Country: HK	Department of Health Drug Office	Identifier(s): 66405
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6583
Country: JP	医薬品医療機器総合機構	Identifier(s): 3929409A1023, 3929409A2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1033699, 1033700
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 176M2011
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 87297, 87300
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13352
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100197198
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64745001, W64745002
Country: SG	Health Sciences Authority	Identifier(s): 13812P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3443131H, 6023131H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636771020
Country: US	FDA, National Drug Code	Identifier(s): 0006-5423, 0006-5425, 71872-7187
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/34/0432